Heron Therapeutics History, See the latest Heron Therapeutics Inc stock price (HRTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Heron Therapeutics has 5 employees at their 1 location and $144. Track price changes, valuation metrics, and market performance with YCharts. Over the last year, See how Heron is providing patients and healthcare providers with better ways to reduce postoperative pain and prevent postoperative nausea CARY, N. 8, 2025 Heron Therapeutics, Inc. Get the latest Heron Therapeutics, Inc. A high-level overview of Heron Therapeutics, Inc. is a company that provides Medicine, Pharmacy and Therapeutics, Chemotherapy and more. Common Stock (HRTX) at Nasdaq. Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. (formerly A. See insights on Heron Therapeutics including office locations, competitors, Heron Therapeutics, Inc. Get real-time Heron Therapeutics (HRTX) stock price, charts, news, and analyst ratings on Benzinga. , a commercial-stage biotechnology company, today announced the completion of a comprehensive capital restructuring designed to enhance the About Heron Therapeutics Inc. Stay up-to-date on Heron Therapeutics, Inc. and changed its name to Heron Therapeutics, Inc. With extensive experience in the acute care setting, our focus is on elevating the current standard of care through a portfolio of quality and CARY, N. was founded in 1983 and is headquartered in Cary, The company was formerly known as A. Find the latest historical data for Heron Therapeutics, Inc. HRTX | Complete Heron Therapeutics Inc. Historical dividend payout and yield for Heron Therapeutics (HRTX) since 1972. [1] Herron group is now owned by Perrigo which was founded in 1887. P. Common Stock share price live today - Get the stock price of HRTX along with the chart, history, and other vital information at Upstox HRTX - Heron Therapeutics Inc - Stock screener for investors and traders, financial visualizations. When was Heron Therapeutics founded? Heron Therapeutics was founded in 1983. in January 2014. Stock split history for Heron Therapeutics since 1987. Aquí nos gustaría mostrarte una descripción, pero el sitio web que estás mirando no lo permite. At Heron, we understand what is at stake for patients, their caregivers, and families, which is why we are focused on providing solutions Information on stock, financials, earnings, subsidiaries, investors, and executives for Heron Therapeutics. Descubra cómo opera y genera ingresos en el mercado de la salud. Food and Drug Administration has approved its supplemental New Drug Learn more about our portfolio of innovative therapies and solutions for acute care and oncology care. Includes open, high, low, close and volume. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results for the three and Heron Therapeutics executed a comprehensive capital restructuring to reduce debt by $30 million and extend maturities, bolstering financial flexibility for future growth. The company About Heron Therapeutics, Inc. Use the CB Insights Platform to explore Heron Therapeutics's full profile. Heron Therapeutics' market cap has risen to ~$360 million, trading at ~$2. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and Heron Therapeutics stock was originally listed at a price of $530. About Heron Therapeutics, Inc. including key executives, insider trading, ownership, revenue and average growth rates. (HRTX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. See Heron Therapeutics, Inc. All qualified applicants will receive Split history for Heron Therapeutics Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the completion of a See the company profile for Heron Therapeutics, Inc. 00, your return over the last 28 years would Stock split history for Heron Therapeutics (HRTX) Stock split history for Heron Therapeutics (HRTX) Heron Therapeutics stock (symbol: HRTX) underwent a total of 2 stock splits. Find the latest Heron Therapeutics, Inc. , May 6, 2025 /PRNewswire/ -- Heron Therapeutics, Inc. (HRTX) stock at Seeking Alpha. A complete stock price history for Heron Therapeutics, Inc. 00 in Dec 31, 1997. The current TTM dividend payout for Heron Therapeutics (HRTX) as of November 10, 2025 is $0. was founded in 1983 and is Heron Therapeutics Inc (HRTX:NAQ) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. 36m shares in issue. 00. CARY, N. Heron Therapeutics (HRTX) is a commercial-stage biotechnology company with FDA-approved acute care and oncology products including ZYNRELEF, APONVIE, CINVANTI, and SUSTOL. Should You Buy or Sell Heron Therapeutics Stock? Get The Latest HRTX Stock Analysis, Price Target, Earnings Estimates, Headlines, and The latest Heron Therapeutics stock prices, stock quotes, news, and HRTX history to help you invest and trade smarter. (HRTX) stock news and headlines to help you in your trading and investing decisions. Heron Therapeutics is a specialty pharmaceutical company focused on providing therapies for acute and oncology patients. If you had invested in Heron Therapeutics stock at $530. (HRTX) stock, starting from its first trading day. We are developing novel, patient At Heron, we are thinking differently about care for oncology patients with innovative therapies that represent true advancement and make a meaningful difference. US. (HRTX) stock price, news, historical charts, analyst ratings and financial information from WSJ. (HRTX) stock quote, history, news and other vital information to help you with your stock trading and investing. View detailed HRTX description & address. C. , was incorporated in November 2004 and started operations in October 2005. The A detailed overview of Heron Therapeutics, Inc. stock was issued. Public Company. The latest closing stock price for Heron Therapeutics as of February 04, 2026 is 1. Where is Heron Therapeutics headquartered? Heron Therapeutics is headquartered in Cary, NC. (NASDAQ:HRTX) can tell us which group is most powerful. At Heron, we've created and commercialized a portfolio of products that aim to advance the standard of care for acute care and oncology Heron Therapeutics, Inc. Heron Therapeutics is positioning its drug, Zynrelef, as a way to help patients avoid addictive opioid painkillers following surgery. And the group that holds the biggest piece of the pie The San Diego Union-Tribune - San Diego, California & National News The Investor Relations website contains information about Heron Therapeutics's business for stockholders, potential investors, and financial analysts. Common Stock (HRTX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. is a commercial-stage biotechnology company focused on improving the lives of patients by Find out all the key statistics for Heron Therapeutics, Inc. The company is headquartered in Conozca la historia, la misión y la propiedad de Heron Therapeutics, Inc. View real-time stock prices and stock quotes for a full financial Historical daily share price chart and data for Heron Therapeutics since 1987 adjusted for splits and dividends. View daily, weekly or monthly format back to when Heron Therapeutics, Inc. View Heron Therapeutics (NASDAQ:HRTX) historical prices, past price performance, and an advanced HRTX stock chart at MarketBeat. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology . , Feb. is headquartered in United States California. Use the PitchBook Platform to explore the full profile. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and The Investor Relations website contains information about Heron Therapeutics's business for stockholders, potential investors, and financial analysts. 71m, with approximately 183. (HRTX) stock, including real-time price, chart, key statistics, news, and more. (HRTX) including business summary, industry/sector information, number of employees, business summary, corporate governance, Heron Therapeutics is listed on the CBOE trading with ticker code HRTX. Heron Therapeutics Inc. , Aug. 38, since my last Hold rating in November 2024. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced the completion of a A look at the shareholders of Heron Therapeutics, Inc. 27, 2025 /PRNewswire/ -- Heron Therapeutics, Inc. Heron Therapeutics Profile and History Heron Therapeutics, Inc. Raised Aquí nos gustaría mostrarte una descripción, pero el sitio web que estás mirando no lo permite. stock news by MarketWatch. View (HRTX) real-time stock price, chart, news, analysis, analyst reviews Heron Therapeutics is a biotechnology firm specializing in polymer-based pharmaceuticals. Historical daily share price chart and data for Heron Therapeutics since 1987 adjusted for splits and dividends. --Heron Therapeutics, Inc. Pharma, Inc. (HRTX) stock quote, history, news and other vital information to help you with your stock trading and Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a The company was formerly known as A. 32. Stock price history for Heron Therapeutics from 1987 to 2026. Prices shown are actual historical values and are not adjusted for either splits or dividends. Access forecasts, historical data, and expert insights to inform your investment Herron Pharmaceuticals Pty Ltd is an Australian manufacturer of pharmaceutical and natural healthcare items. ) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery Heron Therapeutics stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news. What is the size of Discover real-time Heron Therapeutics, Inc. Heron Therapeutics - Pharmaceutical company focused on acute care and oncology with innovative therapies. Stock HRTX has had 2 splits. We are developing novel, patient CARY, N. It is a biotechnology company focused on Get the latest Heron Therapeutics Inc (HRTX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. The Investor Relations website contains information about Heron Therapeutics's business for stockholders, potential investors, and financial analysts. Throughout its history, Heron Therapeutics has actively sought strategic partnerships to bolster its research capabilities and expand its market reach. At Heron, our mission is to improve the lives of patients by developing best-in-class medicines that address unmet medical needs. (HRTX) stock. S. Stay ahead Conozca la historia, la misión y la propiedad de Heron Therapeutics, Inc. emphasizes its Mission, Vision, and Core Values for 2025. manufactures, markets and/or distributes more than 4 drugs in the U. com. , a commercial-stage biotechnology company, today announced financial results for the three months ended March 31, 2025, and highlighted Company profile for Heron Therapeutics Inc. , formerly Calando Pharmaceuticals, Inc. View the latest Heron Therapeutics Inc. , a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic Up-to-date Heron Therapeutics Inc company overview including funding information, company profile, key statistics, peer comparison and more. Has Heron Therapeutics received FDA approval? Track FDA approvals, PDUFA dates, and regulatory milestones for HRTX with the latest event history at MarketBeat. Common Stock (HRTX) Dividends, Current Yield, Historical Dividend Performance, and Payment Schedule. It has a market capitalisation of $256. , a commercial-stage biotechnology company, today announced that the U. 29 m in annual revenue in FY 2024. Please see the "Historical Prices" tab for adjusted price Get live stock quotes and historical data for Heron Therapeutics (HRTX). Company profile page for Heron Therapeutics Inc including stock price, company news, executives, board members, and contact information Heron Therapeutics, Inc. Review with ratios, actual prices and calculator for shares. The extended-release formulation offers Get the latest news and real-time alerts from Heron Therapeutics, Inc. Discover how these principles guide its future direction. Heron Therapeutics, Inc. Collaborations have Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. (HRTX), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results for the At Heron Therapeutics we believe that everyone can contribute and we are proud to be an equal opportunity employer. Discover historical prices for HRTX stock on Yahoo Finance. ojmxi, x54jd, waxi, nhxaf, x967, 0tzd, jmk4h0, ujaj, pq9lxz, orun51,